Skip navigation

The World’s Largest Bio/Pharma Event for Compliance and Legal Professionals

April 16-18, 2019
  • Washington, DC

CBI’s annual Pharmaceutical Compliance Congress is the world’s largest event for compliance and legal professionals in the bio/pharma industry. Backed by 15 years of success, PCC is the industry’s gold standard for compliance excellence, attracting more than 500 industry leaders annually. Join us in April when the brightest minds and most influential stakeholders in the industry unite for three days of high-quality, strategic content delivered by an unparalleled speaking faculty.

Driven by Innovation. Defined by Integrity.

Bryant Aaron
VP, Chief Compliance Officer,
U.S. Country Head,
Ethics and Compliance
Novartis Pharmaceuticals

Sujata Dayal
Vice President, Health Care Compliance and Privacy
Johnson & Johnson

Jill Fallows-Macaluso
Chief Compliance Officer
and Vice President
Novo Nordisk Inc.

Patrik Florencio
Senior Vice President, Global Chief Compliance and Risk Officer
Amicus Therapeutics

Jennifer McGee
Vice President,
Chief Compliance Officer

Gregory Moss
Senior Vice President,
Deputy General Counselor
Kadmon Holdings, Inc

Joe Philipose
Vice President,
US & Enterprise Compliance
Alexion Pharmaceuticals

David Ryan
Vice President and
Chief Compliance Officer

Ann-Marie Tejcek
Senior Director, North American Ethics and Compliance Officer
Eli Lilly and Company

Complimentary Case Study: CIA Vendor Compliance (PDF)

Powerful Compelling Content for Industry
Previous Attendee Acclaim graphic
Reach Out to the #PCC2019 Team to Get Involved:
Contact Info graphic